Cutler Group LP Sarepta Therapeutics, Inc. Transaction History

Cutler Group LP

$307 Million
Q1 2024

A detailed history of Cutler Group LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 6,900 shares of SRPT stock, worth $820,893. This represents 0.29% of its overall portfolio holdings.

Number of Shares

6,900

Previous 18,534 62.77%

Holding current value

$820,893

Previous $1.79 Million 50.03%

% of portfolio

0.29%

Previous 0.16%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$93.7 - $141.53 $1.09 Million - $1.65 Million	-11,634 Reduced 62.77%	6,900 $893,000
Q4 2023 Jan 18, 2024	SELL	$67.31 - $124.76 $368,926 - $683,809	-5,481 Reduced 22.82%	18,534 $1.79 Million
Q3 2023 Nov 07, 2023	BUY	$102.5 - $123.59 $258,710 - $311,941	2,524 Added 11.74%	24,015 $2.91 Million
Q2 2023 Jul 18, 2023	BUY	$106.4 - $157.19 $3,192 - $4,715	30 Added 0.14%	21,491 $2.46 Million
Q1 2023 May 01, 2023	BUY	$117.53 - $155.99 $912,150 - $1.21 Million	7,761 Added 56.65%	21,461 $2.96 Million
Q4 2022 Feb 07, 2023	BUY	$100.86 - $132.13 $181,548 - $237,834	1,800 Added 15.13%	13,700 $1.78 Million
Q3 2022 Oct 25, 2022	SELL	$75.71 - $119.24 $453,124 - $713,651	-5,985 Reduced 33.46%	11,900 $1.32 Million
Q2 2022 Aug 04, 2022	BUY	$62.69 - $88.44 $484,907 - $684,083	7,735 Added 76.21%	17,885 $1.34 Million
Q1 2022 Apr 14, 2022	SELL	$63.15 - $90.42 $1.43 Million - $2.05 Million	-22,680 Reduced 69.08%	10,150 $792,000
Q4 2021 Jan 18, 2022	BUY	$77.28 - $99.42 $566,462 - $728,748	7,330 Added 28.75%	32,830 $2.96 Million
Q3 2021 Oct 26, 2021	BUY	$65.97 - $92.48 $1.42 Million - $2 Million	21,600 Added 553.85%	25,500 $2.36 Million
Q2 2021 Jul 19, 2021	SELL	$69.38 - $86.75 $323,588 - $404,602	-4,664 Reduced 54.46%	3,900 $303,000
Q1 2021 Apr 26, 2021	BUY	$72.25 - $168.95 $452,574 - $1.06 Million	6,264 Added 272.35%	8,564 $638,000
Q3 2020 Oct 27, 2020	SELL	$127.12 - $172.34 $343,351 - $465,490	-2,701 Reduced 54.01%	2,300 $322,000
Q1 2020 May 07, 2020	SELL	$82.38 - $131.64 $568,339 - $908,184	-6,899 Reduced 57.97%	5,001 $489,000
Q4 2019 Feb 06, 2020	BUY	$76.53 - $135.58 $160,713 - $284,718	2,100 Added 21.43%	11,900 $1.54 Million
Q3 2019 Oct 28, 2019	SELL	$72.81 - $156.91 $371,622 - $800,868	-5,104 Reduced 34.25%	9,800 $738,000
Q2 2019 Aug 09, 2019	BUY	$112.21 - $151.95 $987,896 - $1.34 Million	8,804 Added 144.33%	14,904 $2.26 Million
Q1 2019 May 10, 2019	SELL	$106.67 - $151.68 $96,323 - $136,967	-903 Reduced 12.89%	6,100 $727,000
Q4 2018 Feb 05, 2019	BUY	$97.32 - $148.76 $652,044 - $996,691	6,700 Added 2211.22%	7,003 $764,000
Q3 2018 Nov 07, 2018	SELL	$115.31 - $161.51 $2.19 Million - $3.07 Million	-18,978 Reduced 98.43%	303 $48,000
Q2 2018 Aug 10, 2018	BUY	$71.74 - $153.69 $1.21 Million - $2.6 Million	16,926 Added 718.73%	19,281 $2.55 Million
Q1 2018 May 11, 2018	BUY	$54.02 - $82.27 $108,634 - $165,444	2,011 Added 584.59%	2,355 $174,000
Q4 2017 Jan 17, 2018	SELL	$47.64 - $56.75 $314,042 - $374,096	-6,592 Reduced 95.04%	344 $19,000
Q3 2017 Oct 17, 2017	BUY	$35.73 - $47.15 $247,823 - $327,032	6,936	6,936 $314,000

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account